Vistagen Therapeutics Inc (VTGN)
4.75
+0.06
(+1.28%)
USD |
NASDAQ |
Apr 19, 16:00
4.75
0.00 (0.00%)
After-Hours: 20:00
Vistagen Therapeutics Cash from Operations (TTM): -26.09M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -26.09M |
| September 30, 2023 | -31.49M |
| June 30, 2023 | -41.64M |
| March 31, 2023 | -49.72M |
| December 31, 2022 | -57.83M |
| September 30, 2022 | -59.94M |
| June 30, 2022 | -55.05M |
| March 31, 2022 | -45.26M |
| December 31, 2021 | -34.95M |
| September 30, 2021 | -27.89M |
| June 30, 2021 | -15.44M |
| March 31, 2021 | -12.07M |
| December 31, 2020 | -9.371M |
| September 30, 2020 | -8.662M |
| June 30, 2020 | -13.80M |
| March 31, 2020 | -15.76M |
| December 31, 2019 | -16.74M |
| September 30, 2019 | -16.36M |
| June 30, 2019 | -16.15M |
| March 31, 2019 | -14.53M |
| December 31, 2018 | -13.57M |
| September 30, 2018 | -12.11M |
| June 30, 2018 | -10.06M |
| March 31, 2018 | -9.058M |
| December 31, 2017 | -7.748M |
| Date | Value |
|---|---|
| September 30, 2017 | -7.399M |
| June 30, 2017 | -7.725M |
| March 31, 2017 | -7.262M |
| December 31, 2016 | -7.278M |
| September 30, 2016 | -6.352M |
| June 30, 2016 | -5.656M |
| March 31, 2016 | -4.808M |
| December 31, 2015 | -4.393M |
| September 30, 2015 | -3.565M |
| June 30, 2015 | -2.580M |
| March 31, 2015 | -2.769M |
| December 31, 2014 | -2.342M |
| September 30, 2014 | -2.343M |
| June 30, 2014 | -2.406M |
| March 31, 2014 | -2.126M |
| December 31, 2013 | -2.629M |
| September 30, 2013 | -3.249M |
| June 30, 2013 | -3.899M |
| March 31, 2013 | -3.463M |
| December 31, 2012 | -3.212M |
| September 30, 2012 | -3.308M |
| June 30, 2012 | -2.776M |
| March 31, 2012 | -3.566M |
| December 31, 2011 | -2.849M |
| September 30, 2011 | -1.792M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-59.94M
Minimum
Sep 2022
-8.662M
Maximum
Sep 2020
-29.17M
Average
-26.09M
Median
Dec 2023
Cash from Operations (TTM) Benchmarks
| Ardelyx Inc | -89.72M |
| Axsome Therapeutics Inc | -145.08M |
| Vir Biotechnology Inc | -778.78M |
| Immuneering Corp | -48.97M |
| NovaBay Pharmaceuticals Inc | -4.131M |